Literature DB >> 18400491

Ligand structure-dependent activation of estrogen receptor alpha/Sp by estrogens and xenoestrogens.

Fei Wu1, Shaheen Khan, Qian Wu, Rola Barhoumi, Robert Burghardt, Stephen Safe.   

Abstract

This study investigated the effects of E2, diethylstilbestrol (DES), antiestrogens, the phytoestrogen resveratrol, and the xenoestrogens octylphenol (OP), nonylphenol (NP), endosulfan, kepone, 2,3,4,5-tetrachlorobiphenyl-4-ol (HO-PCB-Cl(4)), bisphenol-A (BPA), and 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE) on induction of luciferase activity in breast cancer cells transfected with a construct (pSp1(3)) containing three tandem GC-rich Sp binding sites linked to luciferase and wild-type or variant ERalpha. The results showed that induction of luciferase activity was highly structure-dependent in both MCF-7 and MDA-MB-231 cells. Moreover, RNA interference assays using small inhibitory RNAs for Sp1, Sp3 and Sp4 also demonstrated structure-dependent differences in activation of ERalpha/Sp1, ERalpha/Sp3 and ERalpha/Sp4. These results demonstrate for the first time that various structural classes of ER ligands differentially activate wild-type and variant ERalpha/Sp-dependent transactivation, selectively use different Sp proteins, and exhibit selective ER modulator (SERM)-like activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18400491      PMCID: PMC2519242          DOI: 10.1016/j.jsbmb.2008.02.008

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  42 in total

Review 1.  Hormonal regulation of the NF-kappaB signaling pathway.

Authors:  F Delfino; W H Walker
Journal:  Mol Cell Endocrinol       Date:  1999-11-25       Impact factor: 4.102

Review 2.  Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions.

Authors:  V Craig Jordan
Journal:  J Med Chem       Date:  2003-03-13       Impact factor: 7.446

3.  Ability of structurally diverse natural products and synthetic chemicals to induce gene expression mediated by estrogen receptors from various species.

Authors:  J B Matthews; K C Fertuck; T Celius; Y-W Huang; C J Fong; T R Zacharewski
Journal:  J Steroid Biochem Mol Biol       Date:  2002-10       Impact factor: 4.292

Review 4.  Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.

Authors:  V Craig Jordan
Journal:  J Med Chem       Date:  2003-03-27       Impact factor: 7.446

5.  Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements.

Authors:  B Saville; M Wormke; F Wang; T Nguyen; E Enmark; G Kuiper; J A Gustafsson; S Safe
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

6.  Differential interaction of the methoxychlor metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane with estrogen receptors alpha and beta.

Authors:  K W Gaido; L S Leonard; S C Maness; J M Hall; D P McDonnell; B Saville; S Safe
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

7.  Vascular endothelial growth factor receptor-2 expression is induced by 17beta-estradiol in ZR-75 breast cancer cells by estrogen receptor alpha/Sp proteins.

Authors:  Kelly J Higgins; Shengxi Liu; Maen Abdelrahim; Kyungsil Yoon; Kathryn Vanderlaag; Weston Porter; Richard P Metz; Stephen Safe
Journal:  Endocrinology       Date:  2006-03-30       Impact factor: 4.736

8.  The dynamic and elusive membrane estrogen receptor-alpha.

Authors:  Cheryl S Watson; Celeste H Campbell; Bahiru Gametchu
Journal:  Steroids       Date:  2002-05       Impact factor: 2.668

9.  Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells.

Authors:  Maen Abdelrahim; Ismael Samudio; Roger Smith; Robert Burghardt; Stephen Safe
Journal:  J Biol Chem       Date:  2002-06-06       Impact factor: 5.157

10.  Role of specificity protein transcription factors in estrogen-induced gene expression in MCF-7 breast cancer cells.

Authors:  Shaheen Khan; Fei Wu; Shengxi Liu; Qian Wu; Stephen Safe
Journal:  J Mol Endocrinol       Date:  2007-10       Impact factor: 5.098

View more
  14 in total

1.  Rational quantitative structure-activity relationship (RQSAR) screen for PXR and CAR isoform-specific nuclear receptor ligands.

Authors:  Ann M Dring; Linnea E Anderson; Saima Qamar; Matthew A Stoner
Journal:  Chem Biol Interact       Date:  2010-10-20       Impact factor: 5.192

2.  Moving Toward Integrating Gene Expression Profiling Into High-Throughput Testing: A Gene Expression Biomarker Accurately Predicts Estrogen Receptor α Modulation in a Microarray Compendium.

Authors:  Natalia Ryan; Brian Chorley; Raymond R Tice; Richard Judson; J Christopher Corton
Journal:  Toxicol Sci       Date:  2016-02-10       Impact factor: 4.849

3.  Penfluridol Represses Integrin Expression in Breast Cancer through Induction of Reactive Oxygen Species and Downregulation of Sp Transcription Factors.

Authors:  Erik Hedrick; Xi Li; Stephen Safe
Journal:  Mol Cancer Ther       Date:  2016-11-03       Impact factor: 6.261

Review 4.  Endocrine-disrupting chemicals: associated disorders and mechanisms of action.

Authors:  Sam De Coster; Nicolas van Larebeke
Journal:  J Environ Public Health       Date:  2012-09-06

Review 5.  Endocrine disruptors and falling sperm counts: lessons learned or not!

Authors:  Stephen Safe
Journal:  Asian J Androl       Date:  2012-09-24       Impact factor: 3.285

Review 6.  Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action.

Authors:  Erin K Shanle; Wei Xu
Journal:  Chem Res Toxicol       Date:  2010-11-05       Impact factor: 3.739

Review 7.  Classical nuclear hormone receptor activity as a mediator of complex concentration response relationships for endocrine active compounds.

Authors:  Clifford J Cookman; Scott M Belcher
Journal:  Curr Opin Pharmacol       Date:  2014-10-06       Impact factor: 5.547

8.  The tri-nucleotide spacer sequence between estrogen response element half-sites is conserved and modulates ERalpha-mediated transcriptional responses.

Authors:  Feng-Jue Shu; Neil Sidell; Danzhou Yang; Caleb B Kallen
Journal:  J Steroid Biochem Mol Biol       Date:  2010-04-18       Impact factor: 4.292

9.  Induction of cytochrome P450 1A1 in MCF-7 human breast cancer cells by 4-chlorobiphenyl (PCB3) and the effects of its hydroxylated metabolites on cellular apoptosis.

Authors:  Anna Ptak; Gabriele Ludewig; Agnieszka Rak; Weronika Nadolna; Michał Bochenek; Ewa L Gregoraszczuk
Journal:  Environ Int       Date:  2009-07-14       Impact factor: 9.621

10.  Location analysis for the estrogen receptor-alpha reveals binding to diverse ERE sequences and widespread binding within repetitive DNA elements.

Authors:  Christopher E Mason; Feng-Jue Shu; Cheng Wang; Ryan M Session; Roland G Kallen; Neil Sidell; Tianwei Yu; Mei Hui Liu; Edwin Cheung; Caleb B Kallen
Journal:  Nucleic Acids Res       Date:  2010-01-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.